Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Mol Pharm. 2009 Sep–Oct;6(5):1311–1320. doi: 10.1021/mp900011h

Figure 5.

Figure 5

Viability of HUVEC cells incubated with RNPs and TAT-RNPs conjugated to different amount of peptide. HUVEC cells were grown in 96-well plates at a seeding density of 5,000 cells per well until confluency was attained. Cells were then incubated with RNPs or TAT-RNPs and cell viability was assessed using a MTS assay at different time points following incubation. Ritonavir solution or TAT peptide alone did not show any toxicity (data not included in figure). The values represent percentage of viable cells relative to untreated cells. Data are expressed as mean ± s.e.m. (n = 3).